HomeIPOGlenmark Life Sciences Limited IPO Details

Glenmark Life Sciences Limited IPO Details

- Advertisement -

Glenmark Life Sciences IPO Date, Price, GMP, Review, Allotment, Subscription, Analysis & Documents

About Glenmark Life Sciences

Glenmark Life Science is the leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”) in chronic therapeutic areas, including cardiovascular disease (“CVS”), central nervous system disease (“CNS”), pain management and diabetes.

- Advertisement -

Glenmark Life Science also manufacture and sell APIs for gastro-intestinal disorders, anti-infectives and other therapeutic areas. The API portfolio comprises specialized and profitable products, including niche and technically complex molecules, which company believe reflects the capability to branch into other high value products. The company have strong market share in select specialized APIs such as Telmisartan (anti-hypertensive), Atovaquone (anti-parasitic), Perindopril (anti- hypertensive), Teneligliptin (diabetes), Zonisamide (CNS) and Adapalene (dermatology). 

The company also increasingly providing contract development and manufacturing operations (“CDMO”) services to a range of multinational and specialty pharmaceutical companies. Glenmark Life Science is in a research and development (“R&D”)-driven API manufacturer, focused on undertaking dedicated R&D in the existing products and in areas where they believe there is growth potential in the future. 

Important Details – Glenmark Life Sciences

DateDetails
June 23, 2011The company was incorporated as ‘Zorg Laboratories Private Limited’, a private limited company at Pune.
July 25, 2018The company was acquired by Glenmark Pharmaceuticals Limited and name of the company was changed to ‘Glenmark Life Sciences Private Limited’
August 28, 2018Converted from a private limited company to a public limited company.

Glenmark Life Sciences IPO Price – Details

DescriptionGLS IPO Details
Public IssueInitial Public offer of [.] Equity Shares aggregating upto Rs.[.] million comprising a Fresh Issue of up to Rs. 10,600 million and an Offer for Sale of up to 6,300,000 equity shares
Issue Open  Date27-Jul-21
Issue Close Date29-Jul-21
Issue TypeBook Built 
IPO Price Band₹ 695 to ₹ 720 per equity share
Face Value ₹ 2
Market Lot 20 Equity Shares and in multiples thereof
Minimum Order Quantity 20 Equity Shares
Maximum Subscription Amount for Retail InvestorRs. 2,00,000
Listing BSE, NSE
NSE SymbolGLS
IPO Market Timings 10.00 a.m. to 5.00 p.m.

Glenmark Life Sciences Financials

Summary of financial Information (Restated Consolidated Statement)

Particulars For the year ended (₹ in million)
  31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 19,970.75 17,256.04 14,753.95
Total income 18,859.76 15,493.03 8,868.65
Profit After Tax 3,515.81 3,130.98 1,955.92

Objects of the Issue

  1. Payment of outstanding purchase consideration to the Promoter for the spin-off of the API business from the Promoter into our Company pursuant to the Business Purchase Agreement dated October 9, 2018;
  2. Funding capital expenditure requirements; and
  3. General corporate purposes.

Glenmark Life Sciences IPO Lot Size

ApplicationLotsNo of SharesAmount (Rs)
Minimum12014,400
Maximum132601,87,200

Glenmark Life Sciences IPO Lead Managers

  • BoA Merrill Lynch
  • BOB Capital Markets Limited
  • DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd)
  • Goldman Sachs (India) Securities Private Limited
  • Kotak Mahindra Capital Company Limited
  • SBI Capital Markets Limited

Glenmark Life Sciences Registrar

KFintech Private Limited

Glenmark Life Sciences IPO DRHP & RHP

Glenmark Life Sciences IPO Allotment Date, Listing Date and other Important Dates

DetailsDate
Bid / Offer Opens on27-Jul-21
Bid / Offer Closes on29-Jul-21
Finalisation of Basis of Allotment03-Aug-21
Initiation of refunds 04-Aug-21
Credit of the Equity Shares05-Aug-21
Commencement of trading – Listing06-Aug-21

Glenmark Life Sciences IPO – FAQS

When Glenmark Life Sciences IPO will open ?

The Glenmark Life Sciences IPO opens on July 27, 2021 and closes on July 29, 2021

What is the lot size of Glenmark Life Sciences IPO ?

Glenmark Life Sciences IPO lot size is 20 Shares and the minimum order quantity is 20 Shares.

What is the price band for Glenmark Life Sciences IPO ?

The Glenmark Life Sciences IPO price band from Rs. 695 to Rs.720 per share

Who is the Registrar for Glenmark Life Sciences IPO ?

The Registrar is KFintech Private Limited

How to apply in Glenmark Life Sciences IPO through UPI?

Check the step by step process here – Click here

Follow us on Telegram for all latest updates

- Advertisement -

Leave a IPO Review

IPO Review

Reviews (0)

This article doesn't have any reviews yet.

LEAVE A REPLY

Please enter your comment!
Please enter your name here